Current and future economic burden of diabetes among working-age adults in Asia: Conservative estimates for Singapore from 2010-2050 Chronic Disease epidemiology

BMC Public Health

Volumn 16, Issue 1, 2016, Pages

  Png, May Ee ^a   Yoong, Joanne ^a,b   Phan, Thao Phuong ^a   Wee, Hwee Lin ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cost; Diabetes; Projection; Singapore; Working age

Indexed keywords

ABSENTEEISM; ADULT; AGED; ASIA; COST OF ILLNESS; ECONOMICS; FEMALE; HEALTH CARE COST; HUMAN; MALE; MEDICAL LEAVE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESENTEEISM; PREVALENCE; PRODUCTIVITY; SINGAPORE; YOUNG ADULT;

ABSENTEEISM; ADULT; AGED; ASIA; COST OF ILLNESS; DIABETES MELLITUS, TYPE 2; EFFICIENCY; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; PRESENTEEISM; PREVALENCE; SICK LEAVE; SINGAPORE; YOUNG ADULT;

EID: 84958163729     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-016-2827-1     Document Type: Article

References (43)

1. Huang E, Basu A, O'Grady M, Capretta J. Projecting the future diabetes population size and related costs for the U.S. Diabetes Care. 2009;32:2225-9.
2. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008;31:596-615.
3. González J. Cost-of-illness study of type 2 diabetes mellitus in Colombia. Rev Panam Salud Pública. 2009;26:55-63.
4. Palmer A, Roze S. The CORE Diabetes Model: projecting long-term clinical outcomes, costs and costeffectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making. Curr Med Res Opin. 2004;20 Suppl 1:S5-26.
5. Hex N, Bartlett C, Wright D. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med. 2012;29:855-62.
6. Javanbakht M, Mashayekhi A, Baradaran HR, Haghdoost A, Afshin A. Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis. PLoS One. 2015;10:e0132505.
7. Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: a global systematic review. Pharmacoeconomics. 2015;33:811-31.
8. Economic Impact of Diabetes. https://www.idf.org/sites/default/files/Economic%20impact%20of%20Diabetes-0.pdf. Accessed 22 Sep 2014.
9. Health expenditure, total (% of GDP). [ http://data.worldbank.org/indicator/SH.XPD.TOTL.ZS/countries/SG-8S-7E-Z7-4E-Z4?display=graph ]. Accessed 22 Sep 2014.
10. Huxley R, Omari A, Caterson ID. Obesity and diabetes. In: Ekoé J, Rewers M, Williams R, Zimmet P, editors. The Epidemiology of Diabetes Mellitus. 2nd edn. Chichester: John Wiley & Sons Ltd; 2008. p. 57-70.
11. Yeung R, Zhang Y, Luk A. Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort. Lancet Diabetes Endocrinol. 2014;2:935-43.
12. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36:1033-46.
13. Phan T, Alkema L, Tai E, Tan K. Forecasting the burden of type 2 diabetes in Singapore using a demographic epidemiological model of Singapore. BMJ Open Diabetes Res Care. 2014;2:e000012.
14. National Health Survey 2010. [ http://www.moh.gov.sg/content/moh-web/home/Publications/Reports/2011/national-health-survey2010.html ]. Accessed 22 Sep 2014.
15. Census of Population 2010 Statistical Release 1: Demographic Characteristics, Education, Language and Religion. [ http://www.singstat.gov.sg/publications/publications-and-papers/cop2010/census10-stat-release1 ]. Accessed 22 Sep 2014.
16. Report on Labour Force in Singapore, 2010. [ http://www.mom.gov.sg/Documents/statistics-publications/manpower-supply/report-labour-2010/mrsd-2010LabourForce.pdf ]. Accessed 22 Sep 2014.
17. Report on Labour Force in Singapore, 2011. [ http://www.mom.gov.sg/Documents/statistics-publications/manpower-supply/report-labour-2011/mrsd-2011LabourForce.pdf ]. Accessed 22 Sep 2014.
18. Singapore Yearbook of Manpower Statistics, 2012. [ http://staging.ilo.org/public/libdoc/igo/P/74594/74594(2012)187.pdf ]. Accessed 1 Jun 2015.
19. Tunceli K, Bradley C, Nerenz D. The impact of diabetes on employment and work productivity. Diabetes Care. 2005;28:2662-7.
20. Tunceli K, Zeng H, Habib Z, Williams L. Long-term projections for diabetes-related work loss and limitations among US adults. Diabetes Res Clin Pract. 2009;83:e23-5.
21. Data: Official exchange rate (LCU per US$, period average). [ http://data.worldbank.org/indicator/PA.NUS.FCRF ]. Accessed 22 Sep 2014.
22. Ng CS, Toh M, Ko Y, Lee JY-C. Direct medical cost of type 2 diabetes in Singapore. PLoS One. 2015;10:e0122795.
23. Wu C, Tan W, Toh M, Heng B. Derivation and validation of a risk index to predict all-cause mortality in type 2 diabetes mellitus. J Endocrinol Metab. 2012;2:88-95.
24. Toh M, Leong H, Lim B. Development of a diabetes registry to improve quality of care in the National Healthcare Group in Singapore. Ann Acad Med Singapore. 2009;38:546.
25. Average (Mean) Monthly Earnings Table(s). [ http://stats.mom.gov.sg/Pages/Average-Mean-Monthly-Earnings-Tables2013.aspx ]. Accessed 22 Sep 2014.
26. Saw Swee Hock School of Public Health: Final Report for Integrated Workplace Safety and Health (iWSH) Services to Ministry of Manpower, Singapore. Singapore; 2013.
27. Carter M, May J, Agüero J, Ravindranath S. The economic impacts of premature adult mortality: panel data evidence from KwaZulu-Natal, South Africa. AIDS. 2007;21:S67-73.
28. Chart: Age-Sex Specific Resident Labour Force Participation Rate. [ http://stats.mom.gov.sg/Pages/Age-Sex-Specific-Resident-Labour-Force-Participation-Rate.aspx ]. Accessed 1 Jan 2015.
29. King H, Aubert R, Herman W. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414-31.
30. Narayan K, Boyle J, Geiss L. Impact of recent increase in incidence on future diabetes burden US, 2005-2050. Diabetes Care. 2006;29:2114-6.
31. Amos A, McCarty D, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997;14 Suppl 5:S1-85.
32. Minister Lim Hng Kiang's Written Reply to Parliament Question on Impact Of Low Labour Productivity On Singapore's Economic Growth. [ http://www.mti.gov.sg/NewsRoom/Pages/Minister-Lim-Hng-Kiang%E2%80%99s-Written-Reply-to-Parliament-Question-on-Impact-Of-Low-Labour-Productivity-On-Singapore%E2%80%99s-Economic-.aspx ]. Accessed 5 Jan 2015.
33. R Core Team. R: A language and environment for statistical computing. 2013.
34. What is productivity? [ http://mom-gov.com/enter/Pages/22menu.php ]. Accessed 22 Sep 2014.
35. Ramachandran A, Ma RCW, Snehalatha C. Diabetes in Asia. Lancet. 2010;375:408-18.
36. Economic Survey of Singapore 2010. [ http://www.mti.gov.sg/ResearchRoom/Documents/app.mti.gov.sg/data/article/24221/doc/FinalReport-AES-2010.pdf ]. Accessed 22 Sep 2014.
37. Costs and Financing. [ http://www.moh.gov.sg/content/moh-web/home/costs-and-financing.html ]. Accessed 22 Sep 2014.
38. Gross domestic product (GDP) of the United States of America from 1990 to 2014 (in billion U.S. dollars, current). [ http://www.statista.com/statistics/188105/annual-gdp-of-the-united-states-since-1990/ ]. Accessed 1 Jun 2015.
39. Boyle J, Thompson T, Gregg E. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010;8:29.
40. Wiréhn A, Andersson A. Age-specific direct healthcare costs attributable to diabetes in a Swedish population: a register-based analysis. Diabet Med. 2008;25:732-7.
41. Zhuo X, Zhang P, Hoerger T. Lifetime direct medical costs of treating type 2 diabetes and diabetic complications. Am J Prev Med. 2013;45:253-61.
42. Lai DWL. Effect of Financial Costs on Caregiving Burden of Family Caregivers of Older Adults. SAGE Open. 2012; 2(4):1-14.
43. Png ME, Yoong JS-Y. Evaluating the cost-effectiveness of lifestyle modification versus metformin therapy for the prevention of diabetes in Singapore. PLoS One. 2014;9:e107225.